Geode Capital Management’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Buy |
|
|||||
|
2025
Q1 | $711K | Buy |
|
|||||
|
2024
Q4 | $1.05M | Buy |
|
|||||
|
2024
Q3 | $65.1K | Buy |
|
|||||
|
2024
Q2 | $48.9K | Buy |
|
|||||
|
2024
Q1 | $62K | Hold |
|
|||||
|
2023
Q4 | $36.5K | Hold |
|
|||||
|
2023
Q3 | $40.5K | Buy |
|
|||||
|
2023
Q2 | $51.6K | Sell |
|
|||||
|
2023
Q1 | $58.6K | Hold |
|
|||||
|
2022
Q4 | $44K | Sell |
|
|||||
|
2022
Q3 | $81K | Hold |
|
|||||
|
2022
Q2 | $66K | Buy |
|
|||||
|
2022
Q1 | $124K | Buy |
|
|||||
|
2021
Q4 | $116K | Buy |
|
|||||
|
2021
Q3 | $49K | Buy |
|